Carbidopa/Levodopa Sandoz CR 25/100

Carbidopa/Levodopa Sandoz CR 25/100 is a medicine authorised by Swissmedic under authorisation number 57275. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 June 2007 and the authorisation is valid without a time limit. ATC code N04BA02 places the medicine in the group Anti-Parkinson drugs.

  • Dispensing category B
  • Authorisation number 57275
  • ATC N04BA02
  • Synthetic medicines
Authorisation data
Authorisation number57275
NameCarbidopa/Levodopa Sandoz CR 25/100
Full nameCarbidopa/Levodopa Sandoz CR 25/100, Retardtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN04BA02
First authorisation29 June 2007
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Carbidopa/Levodopa Sandoz CR 25/100, RetardtablettenB29 June 2007
2Carbidopa/Levodopa Sandoz CR 50/200, RetardtablettenB29 June 2007

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
230Tablette(n)N04BA0201.08.0.B
4100Tablette(n)N04BA0201.08.0.B
630Tablette(n)N04BA0201.08.0.B
8100Tablette(n)N04BA0201.08.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Carbidopa/Levodopa Sandoz CR 25/100 authorised in Switzerland?

Yes. Carbidopa/Levodopa Sandoz CR 25/100 is authorised by Swissmedic under authorisation number 57275, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Carbidopa/Levodopa Sandoz CR 25/100 have?

Carbidopa/Levodopa Sandoz CR 25/100 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Carbidopa/Levodopa Sandoz CR 25/100?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com